| Literature DB >> 33588970 |
Khayal Muhammad1, Muhammad Saqlain2, Gul Muhammad3, Ataullah Hamdard4, Muhammad Naveed5, Muhammad Hammad Butt6, Siraj Khan2, Najlaa Saadi Ismael7, Zakir Khan8, Yusuf Karatas8,9.
Abstract
OBJECTIVE: The 2019 coronavirus disease (COVID-19) is a global pandemic with no therapy, and pharmacists being a part of the health care system have a vital role in the management of COVID-19. The purpose of this study is to assess the knowledge, attitude, and practices of community pharmacists (CPs) regarding COVID-19.Entities:
Keywords: COVID-19; KAPs study; awareness; community pharmacists; infections
Year: 2021 PMID: 33588970 PMCID: PMC8129683 DOI: 10.1017/dmp.2021.54
Source DB: PubMed Journal: Disaster Med Public Health Prep ISSN: 1935-7893 Impact factor: 1.385
Demographic characteristics of community pharmacists
| Variable | Frequencies | Percentages |
|---|---|---|
|
| ||
| Male | 205 | 52.2 |
| Female | 188 | 47.8 |
|
| ||
| ≤ 25 years | 124 | 31.5 |
| ≥ 26 years | 269 | 68.5 |
|
| ||
| Married | 114 | 29.0 |
| Single | 279 | 71.0 |
|
| ||
| Owned | 67 | 17.0 |
| Partnership | 42 | 10.7 |
| Employed | 284 | 72.3 |
|
| ||
| ≤ 5 years | 265 | 67.4 |
| > 5 Years | 128 | 32.6 |
|
| ||
| B-Pharm | 6 | 1.5 |
| Pharm-D | 271 | 69.0 |
| Master/MPhil | 107 | 27.2 |
| PhD | 9 | 2.3 |
|
| ||
| Yes | 337 | 85.8 |
| No | 56 | 14.2 |
|
| ||
| Very high concern | 231 | 58.8 |
| High concern | 122 | 31.0 |
| Moderate concern | 35 | 8.9 |
| Low concern | 3 | 0.8 |
| Very low concern | 1 | 0.3 |
Figure 1.The various information sources used by community pharmacists (n = 393).
Figure 2.Practices among community pharmacists regarding COVID-19.
Difference in knowledge, attitude, and practice by sample characteristics
| Variables | Knowledge | Attitude | Practice | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Poor | Good | χ2 ( | Poor | Good | χ2 ( | Poor | Good | χ2( | |
| (n [%]) | (n [%]) | (n [%]) | (n [%]) | (n [%]) | (n [%]) | ||||
|
| 112 (28.5) | 281 (71.5) | 220 (56.0) | 173 (44.0) | 168 (42.7) | 225 (57.3) | |||
|
| 18.78 | 4.789 ( | 5.383 ( | ||||||
| Male | 39 (19.0) | 166 (81.0) | 104 (50.7) | 101 (49.3) | 99 (48.3) | 106 (51.7) | |||
| Female | 73 (38.8) | 115 (61.2) | 116 (61.7) | 72 (38.3) | 69 (36.7) | 119 (63.3) | |||
|
| 0.775 (0.379) | 10.171 (0.001) | 0.049 (0.825) | ||||||
| ≤ 25 years | 39 (31.5) | 85 (68.5) | 84 (67.7) | 40 (32.3) | 52 (41.9) | 72 (58.1) | |||
| ≥ 26 years | 73 (27.1) | 196 (72.9) | 136 (50.6) | 133 (49.4) | 116 (43.1) | 153 (56.9) | |||
|
| 1.827 (0.172) | 0.166 (0.684) | 5.322 ( | ||||||
| Married | 27 (23.7) | 87 (76.3) | 62 (54.4) | 52 (45.6) | 59 (51.8) | 55 (48.2) | |||
| Single | 85 (30.5) | 194 (69.5) | 158 (56.6) | 121 (43.4) | 109 (39.1) | 170 (60.9) | |||
|
| 0.894 (0.674) | 0.832 (0.660) | 0.700 (0.705) | ||||||
| Owned | 16 (23.9) | 51 (76.1) | 35 (52.2) | 32 (47.8) | 26 (38.8) | 41 (61.2) | |||
| Partnership | 12 (28.6) | 30 (71.4) | 22 (52.4) | 20 (47.6) | 17 (40.5) | 25 (59.5) | |||
| Employed | 84 (29.6) | 200 (70.4) | 163 (57.4) | 121 (42.6) | 125 (44.0) | 159 (56.0) | |||
|
| 0.013 (0.909) | 0.259 (0.611) | 2.136 (0.144) | ||||||
| ≤ 5 years | 76 (28.7) | 189 (71.3) | 146 (55.1) | 119 (44.9) | 120 (45.3) | 145 (54.7) | |||
| > 5 Years | 36 (28.1) | 92 (71.9) | 74 (57.8) | 54 (42.2) | 48 (37.5) | 80 (62.5) | |||
|
| 1.760 (0.624) | 6.093 ( | 9.831 ( | ||||||
| B-Pharm | 3 (50.0) | 3 (50.0) | 5 (83.3) | 1 (16.7) | 3 (50.0) | 3 (50.0) | |||
| Pharm-D | 78 (28.8) | 193 (71.2) | 154 (56.8) | 117 (43.2) | 107 (39.5) | 164 (60.5) | |||
| Master/MPhil | 28 (26.2) | 79 (73.8) | 59 (55.1) | 48 (44.9) | 57 (53.3) | 50 (46.7) | |||
| PhD | 3 (33.3) | 6 (66.7) | 2 (22.2) | 7 (77.8) | 1 (11.1) | 8 (88.9) | |||
|
| 0.392 (0.531) | 1.828 (0.176) | 0.320 (0.572) | ||||||
| Yes | 98 (29.1) | 239 (70.9) | 184 (54.6) | 153 (45.4) | 146 (43.3) | 191 (56.7) | |||
| No | 14 (25.0) | 42 (75.0) | 36 (64.3) | 20 (35.7) | 22 (39.3) | 34 (60.7) | |||
|
| 11.603 | 12.886 | 4.576 (0.334) | ||||||
| Very high concern | 68 (29.4) | 163 (70.6) | 113 (48.9) | 118 (51.1) | 97 (42.0) | 134 (58.0) | |||
| High concern | 29 (23.8) | 93 (76.2) | 80 (65.6) | 42 (34.4) | 48 (39.3) | 74 (60.7) | |||
| Moderate concern | 11 (31.4) | 24 (68.6) | 24 (68.6) | 11 (31.4) | 19 (54.3) | 16 (45.7) | |||
| Low concern | 3 (100.0) | 0 (0.0) | 1 (33.3) | 2 (66.7) | 2 (66.7) | 1 (33.3) | |||
| Very low concern | 1(100.0) | (0.0) | 1 (100.0) | (0.0) | 1 (100.0) | 0 (0.0) | |||
Regression analysis for factors associated with good knowledge, attitude, and practice regarding COVID-19
| Variables | Knowledge | Attitude | Practice | |||
|---|---|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |
|
| ||||||
| Male | 1.00 | − | 1.00 | − | 1.00 | − |
| Female | 0.243 (0.135-0.436) |
| 0.859 (0.507-1.455) | 0.572 | 1.79 (1.038-3.086) | |
|
| ||||||
| ≤ 25 years | Reference | − | 1.00 | − | 1.00 | − |
| ≥ 26 years | 1.783 (1.425-2.282) | 0.281 | 2.046 (1.214-3.450) |
| 1.395 (0.822-2.368) | 0.217 |
|
| ||||||
| Married | 1.00 | − | 1.00 | − | 1.00 | − |
| Single | 1.022 (0.562-1.857) | 0.944 | 1.181 (0.708-1.969) | 0.525 | 1.607 (0.955-2.704) | 0.074 |
|
| ||||||
| Owned | 1.00 | − | 1.00 | − | 1.00 | − |
| Partnership | 0.785 (0.180-1.664) | 0.991 | 1.039 (0.440-2.453) | 0.931 | 0.902 (0.379-2.148) | 0.816 |
| Employed | 0.866 (0.426-1.760) | 0.690 | 1.006 (0.550-1.841) | 0.984 | 0.694 (0.377-1.277) | 0.240 |
|
| ||||||
| ≤ 5 years | 1.00 | − | 1.00 | − | 1.00 | − |
| > 5 years | 1.107 (0.671-1.826) | 0.690 | 1.007 (0.638-1.590) | 0.976 | 1.505 (0.944-2.40) |
|
|
| ||||||
| B-Pharm | 1.00 | − | 1.00 | − | 1.00 | − |
| Pharm-D | 2.307 (0.207-25.735) | 0.390 | 4.268 (0.440-41.41) | 0.211 | 1.928 (0.163-5.288) | 0.133 |
| Master/MPhil | 2.707 (0.465-1.748) | 0.281 | 4.663 (0.374-35.83) | 0.265 | 2.618 (1.106-4.621) | 0.193 |
| PhD | 3.541 (0.623-20.139) | 0.497 | 14.16 (0.875-22.95) |
| 6.574 (0.362-11.942) |
|
|
| ||||||
| Yes | 1.00 | − | 1.00 | − | 1.00 | − |
| No | 1.933 (0.942-3.970) | 0.073 | 0.626 (0.333-1.176) | 0.145 | 1.107 (0.585-2.093) | 0.754 |
|
| ||||||
| Very high concern | 1.00 | − | 1.00 | − | 1.00 | − |
| High concern | 0.991 (0.496-1.793) | 0.220 | 3.496 (0.308-3.800) |
| 0.491 | |
| Moderate concern | 0.878 (0.496-1.793) | 0.278 | 3.443 (0.200-3.980) |
| 0.528 | |
| Low concern | 0.799 (0.013-1.071) | 0.999 | 2.498 (0.198-3.193) | 0.479 | 0.453 | |
| Very low concern | 0.782 (0.019-1.028) | 0.999 | 2.368 (0.143-3.872) | 0.899 | 0.899 | |
|
| − | − | ||||
| Poor | − | − | 1.00 | − | 1.00 | − |
| Good | − | − | 2.045 (1.233-3.391) |
| 2.448 (1.485-2.376) |
|
|
| − | − | − | − | ||
| Poor | − | − | − | − | 1.00 | − |
| Good | − | − | − | − | 1.518 (0.970-2.376) |
|
Correlation between scores of knowledge, attitude, and practice
| Variable | Correlation Coefficient |
|
|---|---|---|
| Knowledge-Attitude | 0.274 |
|
| Attitude-Practice | 0.170 | 0.001 |
| Knowledge-Practice | 0.341 | < 0.001 |
Correlation significant at 0.05 level (2-tailed).